Pharma Industry Consortium to Present Data from large Ketamine-challenge Study at CNS Summit
ERP Biomarker Qualification ConsortiumThe ERP Biomarker Qualification Consortium announced today that they will be presenting data from a recently completed, pharma industry sponsored study that measured the electrophysiologic effects of ketamine on healthy brain function, at the CNS Summit 2023 in Boston.